Inventor
SERRANO-WU MICHAEL H
US29 patents
⚠️ This page may combine multiple inventors who share the name “SERRANO-WU MICHAEL H”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BAYER AG
6 patentsUS10981932B2Apr 20, 2021
Macrocyclic indole derivatives
BAYER AG9 citations83
US11492358B1Nov 8, 2022
Macrocyclic indole derivatives
BAYER AG3 citations71
US11478451B1Oct 25, 2022
Macrocyclic chlorine substituted indole derivatives
BAYER AG3 citations71
US11447504B2Sep 20, 2022
Macrocyclic chlorine substituted indole derivatives
BAYER AG3 citations71
US11440923B2Sep 13, 2022
Substituted macrocyclic indole derivatives
BAYER AG3 citations71
US11891404B2Feb 6, 2024
Substituted macrocyclic indole derivatives
BAYER AG1 citations61
BROAD INST INC
5 patentsUS10329257B2Jun 25, 2019
Compositions and methods for treating tuberculosis
BROAD INST INC2 citations73
US11401278B2Aug 2, 2022
Macrocyclic indole derivatives
BROAD INST INC3 citations71
US11286263B2Mar 29, 2022
Macrocyclic fluorine substituted indole derivatives
BROAD INST INC3 citations71
US12152041B2Nov 26, 2024
Macrocyclic fluorine substituted indole derivatives
BROAD INST INC1 citations61
US10745356B2Aug 18, 2020
Compositions and methods for treating tuberculosis
BROAD INST INC0 citations52
ADAMS CHRISTOPHER MICHAEL
4 patentsUS9056874B2Jun 16, 2015
Complement pathway modulators and uses thereof
ADAMS CHRISTOPHER MICHAEL95 citations96
US9475806B2Oct 25, 2016
Complement factor B inhibitors and uses there of
ADAMS CHRISTOPHER MICHAEL6 citations71
US8846656B2Sep 30, 2014
Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as C5a receptor modulators
ADAMS CHRISTOPHER MICHAEL2 citations59
US9505755B2Nov 29, 2016
Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as C5A receptor modulators
ADAMS CHRISTOPHER MICHAEL0 citations48
ASTRAZENECA AB
4 patentsUS11248001B2Feb 15, 2022
PCSK9 inhibitors and methods of use thereof
ASTRAZENECA AB6 citations80
US11603523B2Mar 14, 2023
PCSK9 inhibitors and methods of use thereof
ASTRAZENECA AB3 citations66
US12552807B2Feb 17, 2026
PCSK9 inhibitors and methods of use thereof
ASTRAZENECA AB0 citations57
US12584120B2Mar 24, 2026
PCSK9 inhibitors and methods of use thereof
ASTRAZENECA AB0 citations56
ANJI PHARMACEUTICALS INC
3 patentsUS11819495B2Nov 21, 2023
Compositions and methods for treating severe constipation
ANJI PHARMACEUTICALS INC1 citations70
US11224590B2Jan 18, 2022
Compositions and methods for treating severe constipation
ANJI PHARMACEUTICALS INC2 citations70
US11679146B2Jun 20, 2023
Compositions and methods for treating pancreatitis
ANJI PHARMACEUTICALS INC0 citations53